Advanced Echocardiography Findings of HER2-Positive Breast Cancer Patients Following Anthracycline-Based Chemotherapy

AuthorAzin Alizadehaslen
AuthorMehrdad Haghazalien
AuthorHamed Bazrafshan Drissien
AuthorAmir Askarinejaden
AuthorSeyed Amirhossein Emamien
AuthorSeyed Asadollah Mousavien
AuthorMohammad Vaezien
AuthorKamran Roudinien
AuthorRobab Anbiaieen
AuthorPayam Azadehen
AuthorMaedeh Barahmanen
AuthorFeridoun Noohien
AuthorMaryam Yazdanien
OrcidAzin Alizadehasl [0000-0002-8550-1378]en
OrcidMehrdad Haghazali [0000-0001-6683-9747]en
OrcidHamed Bazrafshan Drissi [0000-0002-5705-3504]en
OrcidAmir Askarinejad [0000-0003-2803-079X]en
OrcidSeyed Amirhossein Emami [0000-0001-8524-2495]en
OrcidMohammad Vaezi [0000-0002-3186-5491]en
OrcidKamran Roudini [0000-0003-0166-0505]en
OrcidRobab Anbiaie [0000-0001-7997-7479]en
OrcidMaedeh Barahman [0000-0003-0660-0069]en
OrcidMaryam Yazdani [0000-0002-7073-3213]en
Issued Date2022-09-30en
AbstractBackground: Cardiotoxicity, a common complication of chemotherapy, may have irreversible adverse effects on the heart. Anthracycline-based chemotherapy for breast cancer can lead to dilation-hypokinetic cardiomyopathy, eventuating in heart failure. As the primary diagnostic tool for cardiovascular toxicity, echocardiography may be essential in evaluating the heart function of such patients.en
DOIhttps://doi.org/en
URIhttps://brieflands.com/journals/ircrj/articles/128445en
KeywordCardiotoxicityen
KeywordEchocardiographyen
KeywordBreast Neoplasmsen
KeywordThree-Dimensional Echocardiographyen
PublisherBrieflandsen
TitleAdvanced Echocardiography Findings of HER2-Positive Breast Cancer Patients Following Anthracycline-Based Chemotherapyen
TypeResearch Articleen

Files